GGrantIndex
Sort

85,873 grants matching alzheimers

Oregon Alzheimer's Disease Center

$1,188,310
Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2006 · AG

University of Kansas Alzheimer's Disease Core Center

$1,188,255
Russell H Swerdlow · University Of Kansas Medical Center · P30 · FY2013 · AG

Roybal Center for Dementia Family Caregiver Mastery

$1,187,665
Ken W Hepburn · Emory University · P30 · FY2024 · AG

TDP-43 Proteinopathies in ALS-Dementia

$1,187,434
Virginia M Lee · University Of Pennsylvania · P01 · FY2010 · AG

Oregon Alzheimer's Disease Center

$1,187,010
Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2007 · AG

Epigenome Interactions in Complex Neurogenetic Disorders

$1,186,731
Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · NS

Boston University Alzheimer's Disease Core Center

$1,186,683
Boston University Medical Campus · P30 · FY2004 · AG

Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)

$1,186,626
Michael D Geschwind · University Of California, San Francisco · R01 · FY2021 · AG

Smartphone phenotype collection for diagnostic screening of mild cognitive impairment

$1,186,625
Steven L Armentrout · Parabon Nanolabs, Inc. · R44 · FY2021 · AG

Boston University Alzheimer's Disease Core Center

$1,185,888
Boston University Medical Campus · P30 · FY2005 · AG

Apoptosis In Neurodegenerative Disorders

$1,185,744
Mark P Mattson · National Institute On Aging · Z01 · FY2008 · AG

Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)

$1,185,575
Kristen Dams-O'Connor · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG

Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project

$1,185,537
Robert Scott Mackin · University Of California, San Francisco · R01 · FY2022 · MH

METRIcAL - Music & MEmory: a Pragmatic TRIal for Nursing Home Residents with ALzheimer's Disease

$1,184,860
Vincent Mor · Brown University · R33 · FY2020 · AG

Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease

$1,184,668
Joel H Kramer · University Of California, San Francisco · UH3 · FY2019 · NS

Systems Genetics Analysis of Resilience to Alzheimer’s disease

$1,184,638
Catherine Cook Kaczorowski · Jackson Laboratory · R01 · FY2017 · AG

Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia

$1,184,420
Konstantinos Arfanakis · Rush University Medical Center · U01 · FY2023 · NS

Do auditory tests predict future Alzheimer’s disease pathophysiology

$1,183,821
Jay C Buckey · Dartmouth College · R01 · FY2025 · AG

Administrative Core

$1,183,519
Bradley T Hyman · Massachusetts General Hospital · P30 · FY2021 · AG

Alzheimer's Disease Therapeutic

$1,183,503
Trevor P. Castor · Aphios Corporation · R44 · FY2012 · AG

Chaperome networks in Alzheimer's disease

$1,183,214
Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2023 · AG

Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling

$1,183,074
Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE

Syringe-Injectable Mesh Electronics for Seamless Integration with the Central Nervous System

$1,183,000
Charles M Lieber · Harvard University · DP1 · FY2017 · EB

Syringe-Injectable Mesh Electronics for Seamless Integration with the Central Nervous System

$1,183,000
Charles M Lieber · Harvard University · DP1 · FY2019 · EB

Syringe-Injectable Mesh Electronics for Seamless Integration with the Central Nervous System

$1,183,000
Charles M Lieber · Harvard University · DP1 · FY2018 · EB